- Report
- July 2024
- 120 Pages
Global
From €4533EUR$4,750USD£3,798GBP
- Report
- August 2023
- 102 Pages
Global
From €3500EUR$3,929USD£3,035GBP
'''Bovine Blood Plasma Derivatives in Blood Banking'''
Within the field of blood banking, bovine blood plasma derivatives represent a niche category that deals with products derived from the plasma of cattle. These derivatives encompass a diverse range of substances including, but not limited to, bovine serum albumin, immunoglobulins, and clotting factors. They are used in various applications such as pharmaceuticals, diagnostics, cell culture media, and research. Bovine plasma derivatives offer alternatives to human blood products, which can be advantageous in managing supply constraints or reducing the risk of human blood-borne pathogens.
The processing of bovine blood into plasma derivatives involves collection, fractionation, and purification steps that ensure the safety and efficacy of the final products. The blood banking techniques employed mirror those used in human blood processing, adhering to stringent regulatory standards to ensure product quality and safety. These derivatives are critically important in areas such as vaccine production, where they can serve as stabilizers or growth mediums.
'''Companies in the Bovine Blood Plasma Derivatives Market'''
Some notable companies operating within the bovine blood plasma derivatives market include Thermo Fisher Scientific, Merck KGaA, Rocky Mountain Biologicals, Lake Immunogenics, LAMPIRE Biological Laboratories, and Bovogen Biologicals Pty Ltd. Each company contributes to the market with its specialized line of products and expertise, serving a broad range of clients in biomedical fields, including vaccine development, diagnostic manufacturing, and biological research. Show Less Read more